| Literature DB >> 26948522 |
Bodil B Carstens1, Géza Berecki2, James T Daniel3, Han Siean Lee3, Kathryn A V Jackson3, Han-Shen Tae2,4, Mahsa Sadeghi2,4, Joel Castro5, Tracy O'Donnell5, Annemie Deiteren5, Stuart M Brierley5, David J Craik1, David J Adams2,4, Richard J Clark6.
Abstract
α-Conotoxins are disulfide-rich peptides that target nicotinic acetylcholine receptors. Recently we identified several α-conotoxins that also modulate voltage-gated calcium channels by acting as G protein-coupled GABA(B) receptor (GABA(B)R) agonists. These α-conotoxins are promising drug leads for the treatment of chronic pain. To elucidate the diversity of α-conotoxins that act through this mechanism, we synthesized and characterized a set of peptides with homology to α-conotoxins known to inhibit high voltage-activated calcium channels via GABA(B)R activation. Remarkably, all disulfide isomers of the active α-conotoxins Pu1.2 and Pn1.2, and the previously studied Vc1.1 showed similar levels of biological activity. Structure determination by NMR spectroscopy helped us identify a simplified biologically active eight residue peptide motif containing a single disulfide bond that is an excellent lead molecule for developing a new generation of analgesic peptide drugs.Entities:
Keywords: analgesics; calcium channel; drug design; peptides; structure-activity relationships
Mesh:
Substances:
Year: 2016 PMID: 26948522 DOI: 10.1002/anie.201600297
Source DB: PubMed Journal: Angew Chem Int Ed Engl ISSN: 1433-7851 Impact factor: 15.336